B+L Receives FDA Approval for enVista Envy IOL episode artwork

EPISODE · Oct 16, 2024 · 4 MIN

B+L Receives FDA Approval for enVista Envy IOL

from Eyewire News: The Podcast · host Eyewire News

Bausch + Lomb receives FDA approval for a new IOL on its enVista platform; Nanoscope advances it gene therapy for retinitis pigmentosa; and Orasis completes a major funding round to support the launch of its presbyopia eye drop.  Learn more about your ad choices. Visit megaphone.fm/adchoices

NOW PLAYING

B+L Receives FDA Approval for enVista Envy IOL

0:00 4:41

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Frequently Asked Questions

How long is this episode of Eyewire News: The Podcast?

This episode is 4 minutes long.

When was this Eyewire News: The Podcast episode published?

This episode was published on October 16, 2024.

What is this episode about?

Bausch + Lomb receives FDA approval for a new IOL on its enVista platform; Nanoscope advances it gene therapy for retinitis pigmentosa; and Orasis completes a major funding round to support the launch of its presbyopia eye drop.  Learn more about...

Can I download this Eyewire News: The Podcast episode?

Yes, you can download this episode by clicking the download button on the episode player, or subscribe to the podcast in your preferred podcast app for automatic downloads.
URL copied to clipboard!